FDA Panel Delivers Mixed Views for Two New Opioids FDA Panel Delivers Mixed Views for Two New Opioids

An FDA advisory committee gives the nod to a sublingual opioid, but amid loud criticism around safety, while narrowly recommending against approval for an intravenous preparation.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news